Roche Pledges $50 Billion US Investment Amidst Tariffs

Major US Investment by Roche

• 🇨🇭 Swiss healthcare giant Roche announced a significant investment of $50 billion in the United States over the next five years.
• 🎯 This move is one of the largest inward investment pledges by a major company as they navigate President Donald Trump's global tariffs policy.

Job Creation and Economic Impact

• 📈 The investment is expected to create over 12,000 jobs, with nearly 6,500 of those during the construction phase.
• 🏭 Roche plans to establish new research facilities and expand manufacturing operations in states including Indiana, Pennsylvania, Massachusetts, and California.
• 🇺🇸 Upon completion, Roche anticipates exporting more drugs from the US than it imports, reinforcing its commitment to the country where it already employs 25,000 people.

Context of Tariffs and Pharmaceutical Exemptions

• ⚠️ While medicines are currently exempt from Trump's tariffs, this status could change, prompting companies to act.
• ⚡ The announcement follows a similar pledge by Swiss rival Novartis to invest $23 billion in the US.
• 🗣️ Roche's CEO, Thomas Shineker, highlighted the investment as a testament to the company's commitment to the US market.